HARS2 and glioblastoma: HARS2 encodes a mitochondrial histidyl tRNA synthetase, mutation of which causes ovarian dysgenesis and sensorineural hearing loss.41 Although not attaining an exome-wide significant burden of germline variants, additionally of note is CDH18 and GBM risk.